Skip to main content

Ballal Rahul D.

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Ballal Rahul D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

AGIO Agios Pharmaceuticals, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 12, 2024 (view filing)Nov 7-85 daysBallal Rahul D.DirectorSSale−20.0K$55.86−$1.12M−71.4%7.99K after5 lots10b5-1

ELVN Enliven Therapeutics, Inc.

Director7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 10, 2024 (view filing)Oct 82 daysBallal Rahul D.DirectorSSale−10.4K$28.17−$293.5K−31.8%22.3K after10b5-1
Apr 12, 2024 (view filing)Apr 10-112 daysBallal Rahul D.DirectorSSale−67.0K$23.36−$1.57M−75.0%22.3K after4 lots10b5-1
Apr 8, 2024 (view filing)Apr 44 daysBallal Rahul D.DirectorSSale−3.48K$19.15−$66.7K−13.5%22.3K after10b5-1
Apr 3, 2024 (view filing)Apr 12 daysBallal Rahul D.DirectorSSale−3.24K$19.08−$61.8K−12.7%22.3K after10b5-1
Mar 22, 2024 (view filing)Mar 202 daysBallal Rahul D.DirectorSSale−13.3K$19.16−$254.4K−37.3%22.3K after10b5-1
Feb 22, 2023 (view filing)Feb 22Same dayBallal Rahul D.Chief Executive OfficerSSale−32.9K$4.66−$153.1K−27.2%87.8K after
Feb 1, 2023 (view filing)Jan 302 daysBallal Rahul D.Chief Executive OfficerSSale−11.3K$3.91−$44.2K−8.6%120.7K after